Koers Chinook Tyee Industry Ltd Toronto S.E.
Aandelen
GBI.H
CA16961T2083
Farmaceutische producten
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 322K 236K 217K |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -1 mln. -733K -675K | Nettowinst (verlies) 2023 | - 0 0 | EV/omzet 2022 | - |
Nettoschuld 2022 | 3,15 mln. 2,31 mln. 2,13 mln. | Nettoschuld 2023 | 2,77 mln. 2,03 mln. 1,87 mln. | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-1,79
x | K/w-verhouding 2023 |
-1,08
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 74,11% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Tom Kusumoto
CEO | Chief Executive Officer | 54 | 14-12-12 |
Director/Board Member | 72 | 05-12-18 | |
Investor Relations Contact | - | 01-01-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Tom Kusumoto
CEO | Chief Executive Officer | 54 | 14-12-12 |
Director/Board Member | 72 | 05-12-18 | |
Frank Otto
BRD | Director/Board Member | - | 11-05-22 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+41,06% | 6,19 mld. | |
-15,95% | 4,48 mld. | |
+6,39% | 3,29 mld. | |
-13,10% | 3,12 mld. | |
-4,17% | 2,5 mld. | |
+45,47% | 1,94 mld. | |
-9,11% | 1,68 mld. | |
-0,67% | 1,64 mld. | |
-11,32% | 1,56 mld. |